Get the Stockscreener App
18.90
0.84%
-0.16
Si Bone Inc stock is traded at $18.90, with a volume of 485.06K.
It is down -0.84% in the last 24 hours and up +14.89% over the past month.
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
See More
Previous Close:
$19.06
Open:
$19.29
24h Volume:
485.06K
Relative Volume:
1.11
Market Cap:
$805.41M
Revenue:
$150.71M
Net Income/Loss:
$-40.85M
P/E Ratio:
-18.71
EPS:
-1.01
Net Cash Flow:
$-25.98M
1W Performance:
+0.00%
1M Performance:
+14.89%
6M Performance:
+39.79%
1Y Performance:
+41.47%
1-Day Range:
$18.79
$19.33
1-Week Range:
$18.37
$19.33
52-Week Range:
$11.70
$20.05
Si Bone Inc Stock (SIBN) Company Profile
Name
Si Bone Inc
Sector
Industry
Phone
(408) 207-0700
Address
471 EL CAMINO REAL, SUITE 101, SANTA CLARA, CA
Compare SIBN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SIBN
Si Bone Inc
|
18.90 | 805.41M | 150.71M | -40.85M | -25.98M | -1.01 |
|
ABT
Abbott Laboratories
|
133.58 | 232.41B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.09 | 155.73B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
383.89 | 146.23B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.44 | 106.37B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.52 | 45.88B | 5.54B | 4.18B | 623.10M | 7.00 |
Si Bone Inc Stock (SIBN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-06-24 | Reiterated | Needham | Buy |
| Mar-28-24 | Initiated | Piper Sandler | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Apr-07-22 | Resumed | Cantor Fitzgerald | Overweight |
| Jun-08-21 | Initiated | Citigroup | Buy |
| Mar-09-21 | Reiterated | Needham | Buy |
| Dec-16-20 | Reiterated | Needham | Buy |
| Aug-04-20 | Reiterated | Needham | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| May-05-20 | Reiterated | Needham | Buy |
| Feb-19-20 | Initiated | Needham | Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Dec-18-19 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-12-18 | Initiated | BofA/Merrill | Buy |
| Nov-12-18 | Initiated | Canaccord Genuity | Buy |
| Nov-12-18 | Initiated | JMP Securities | Mkt Outperform |
| Nov-12-18 | Initiated | Morgan Stanley | Overweight |
View All
Si Bone Inc Stock (SIBN) Latest News
SI-BONE to Truist Securities MedTech Conference on June 17, 2025 - GuruFocus
SI-BONE to Truist Securities MedTech Conference on June 17, 2025 | SIBN Stock News - GuruFocus
SI-BONE Leadership Hosts Exclusive Fireside Chat at Major MedTech Investment Conference - Stock Titan
When the Price of (SIBN) Talks, People Listen - news.stocktradersdaily.com
SI-BONE, Inc. (NASDAQ:SIBN) Stock Position Increased by Bank of America Corp DE - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Acquires 988 Shares of SI-BONE, Inc. (NASDAQ:SIBN) - Defense World
SI-BONE, Inc. (NASDAQ:SIBN) Shares Purchased by Deutsche Bank AG - Defense World
SI-BONE to Present at Goldman Sachs 46th Global Healthcare Confe - GuruFocus
SI-BONE to Present at Goldman Sachs 46th Global Healthcare Conference on June 10, 2025 | SIBN Stock News - GuruFocus
SI-BONE to Present at Goldman Sachs 46th Global Healthcare Conference on June 10, 2025 - The Manila Times
Medical Device Leader SI-BONE Sets Key Investor Presentation at Goldman Sachs Healthcare Conference - Stock Titan
Wall Street Analysts See a 34.22% Upside in Si-Bone (SIBN): Can the Stock Really Move This High? - Yahoo Finance
SI-BONE’s SWOT analysis: stock poised for growth amid market expansion - Investing.com India
Trend Tracker for (SIBN) - news.stocktradersdaily.com
Have Insiders Sold SI-BONE Shares Recently? - simplywall.st
SI-BONE: Q1 Sales +25%, Loses $7.5 million - Orthopedics This Week
Northern Trust Corp Increases Holdings in SI-BONE, Inc. (NASDAQ:SIBN) - Defense World
SI-BONE Executives Sell Shares to Cover Tax Obligations - TradingView
BNP Paribas Financial Markets Sells 3,886 Shares of SI-BONE, Inc. (NASDAQ:SIBN) - Defense World
Insider Sell: Anshul Maheshwari Sells 4,937 Shares of SI-BONE In - GuruFocus
4 Recent Earnings Winners Riding Fresh Momentum in May - Investing.com
Price T Rowe Associates Inc. MD Buys 3,318 Shares of SI-BONE, Inc. (NASDAQ:SIBN) - Defense World
4 Recent Earnings Winners Riding Fresh Momentum in May - The Globe and Mail
What Makes Si-Bone (SIBN) a Strong Momentum Stock: Buy Now? - Yahoo Finance
Dimensional Fund Advisors LP Has $4.97 Million Holdings in SI-BONE, Inc. (NASDAQ:SIBN) - Defense World
Insider Sell: Anshul Maheshwari Sells 33,287 Shares of SI-BONE I - GuruFocus
Insider Sell: Anshul Maheshwari Sells 33,287 Shares of SI-BONE Inc (SIBN) - GuruFocus
Trading Day Review: SI-BONE Inc (SIBN) Gains Momentum, Closing at 18.33 - DWinneX
Earnings Update: SI-BONE, Inc. (NASDAQ:SIBN) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts - simplywall.st
SI-BONE To Present at BofA Securities 2025 Healthcare Conference on May 13, 2025 - marketscreener.com
Wall Street Analysts Think Si-Bone (SIBN) Could Surge 41.21%: Read This Before Placing a Bet - Yahoo Finance
Revenues Tell The Story For SI-BONE, Inc. (NASDAQ:SIBN) As Its Stock Soars 30% - simplywall.st
Cantor Fitzgerald maintains SI-BONE stock with $25 target By Investing.com - Investing.com Nigeria
SI-BONE, Inc. (NASDAQ:SIBN) Q1 2025 Earnings Call Transcript - Insider Monkey
The 15% return this week takes SI-BONE's (NASDAQ:SIBN) shareholders three-year gains to 25% - simplywall.st
SI-BONE First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
MetLife Investment Management LLC Boosts Holdings in SI-BONE, Inc. (NASDAQ:SIBN) - Defense World
Wells Fargo & Company MN Buys 5,519 Shares of SI-BONE, Inc. (NASDAQ:SIBN) - Defense World
SI-BONE (SIBN) Receives Price Target Increase from Truist Securi - GuruFocus
SI-BONE (SIBN) Receives Reiterated Overweight Rating from Cantor Fitzgerald | SIBN Stock News - GuruFocus
SI-BONE To Present at BofA Securities 2025 Healthcare Conference on May 13, 2025 | SIBN Stock News - GuruFocus
SI-Bone (SIBN) Target Price Lifted by Truist Following Strong Q1 Performance | SIBN Stock News - GuruFocus
SI-BONE (SIBN) Receives Price Target Increase from Truist Securities | SIBN Stock News - GuruFocus
SI-BONE (SIBN): Analyst Reiterates Buy Rating and Target Price | - GuruFocus
Cantor Fitzgerald maintains SI-BONE stock with $25 target - Investing.com
JMP maintains SI-BONE stock with $32 target post-earnings By Investing.com - Investing.com Nigeria
JMP maintains SI-BONE stock with $32 target post-earnings - Investing.com
Forecasting The Future: 6 Analyst Projections For SI-BONE - Benzinga
SI-Bone price target raised to $22 from $20 at Truist - TipRanks
SI-BONE Inc (SIBN) Q1 2025 Earnings Call Highlights: Strong Reve - GuruFocus
Si Bone Inc Stock (SIBN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Si Bone Inc Stock (SIBN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| FRANCIS LAURA | Chief Executive Officer |
May 16 '25 |
Sale |
19.67 |
12,385 |
243,670 |
495,170 |
| FRANCIS LAURA | Chief Executive Officer |
May 19 '25 |
Sale |
19.49 |
5,412 |
105,464 |
490,987 |
| Maheshwari Anshul | Chief Financial Officer |
May 16 '25 |
Sale |
19.76 |
9,585 |
189,399 |
224,507 |
| Maheshwari Anshul | Chief Financial Officer |
May 19 '25 |
Sale |
19.48 |
2,424 |
47,213 |
222,083 |
| RECUPERO ANTHONY J | President, Commercial Ops |
May 16 '25 |
Sale |
19.56 |
4,147 |
81,109 |
282,015 |
| Pisetsky Michael A | SVP, Ops & Adm/Chief Legal Ofr |
May 16 '25 |
Sale |
19.66 |
3,459 |
68,006 |
264,636 |
0.56%
1.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):